Eagle Global Advisors LLC Reata Pharmaceuticals Inc Transaction History

Eagle Global Advisors LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$20.71 - $36.5 $177,381 - $312,622	-8,565 Closed	0 $0
Q1 2022 Apr 20, 2022	SELL	$24.12 - $39.6 $84,902 - $139,392	-3,520 Reduced 29.13%	8,565 $281,000
Q4 2021 Feb 01, 2022	SELL	$25.61 - $110.96 $1.22 Million - $5.29 Million	-47,690 Reduced 79.78%	12,085 $319,000
Q3 2021 Nov 15, 2021	BUY	$100.0 - $143.02 $2.54 Million - $3.64 Million	25,420 Added 73.99%	59,775 $6.01 Million
Q2 2021 Jul 15, 2021	BUY	$78.27 - $151.29 $669,208 - $1.29 Million	8,550 Added 33.13%	34,355 $4.86 Million
Q1 2021 May 07, 2021	BUY	$94.25 - $132.81 $95,663 - $134,802	1,015 Added 4.09%	25,805 $2.57 Million
Q4 2020 Feb 01, 2021	BUY	$102.03 - $184.62 $286,704 - $518,782	2,810 Added 12.78%	24,790 $3.07 Million
Q3 2020 Oct 22, 2020	BUY	$93.53 - $163.34 $231,954 - $405,083	2,480 Added 12.72%	21,980 $2.14 Million
Q2 2020 Aug 14, 2020	BUY	$126.3 - $176.56 $1.45 Million - $2.02 Million	11,450 Added 142.24%	19,500 $3.04 Million
Q1 2020 May 06, 2020	BUY	$124.16 - $247.74 $68,288 - $136,257	550 Added 7.33%	8,050 $1.16 Million
Q2 2019 Aug 13, 2019	BUY	$77.72 - $94.35 $85,492 - $103,785	1,100 Added 17.19%	7,500 $708,000
Q1 2019 Apr 22, 2019	BUY	$51.9 - $101.79 $20,760 - $40,716	400 Added 6.67%	6,400 $547,000
Q4 2018 Jan 30, 2019	BUY	$48.76 - $76.44 $292,560 - $458,640	6,000 New	6,000 $337,000

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Eagle Global Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Eagle Global Advisors LLC with notifications on news.